Clinical Trials Directory

Trials / Completed

CompletedNCT01584180

A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad (iCOOL 3)

iCOOL 3 (Induction of COOLing 3): A Randomized Trial Comparing 2 Methods for Rapid Induction of Cooling in Stroke Patients, Cold Infusions vs. EMCOOLS Brain.Pad

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Hospital Heidelberg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mild hypothermia improves outcome in patients with global cerebral ischemia after cardiac arrest. Hypothermia seems promising also in other acute hypoxic-ischemic or in brain swelling associated cerebrovascular disease. The narrow-time-frame is a major issue ("time is brain"). To provide immediate cooling without delay, easy to use, mobile and effective methods are needed. Cold infusions (4 °C) are an accepted standard worldwide. EMCOOLS Brain.Pad (Emergency Medical Cooling Systems AG, Wien, Austria) is a new non-invasive surface cooling system. A comparison of these two induction methods has never been done before. Neither was the effect of the EMCOOLS Brain.Pad on brain-temperature measured. For the first time iCOOL 3 compares feasibility, safety and efficacy of the two methods.

Conditions

Interventions

TypeNameDescription
DRUGCold crystalloid infusions, 0.9%NaCl or Ringer'sInfusion of max. 1L cold crystalloid solution (4°C) over 15 minutes
DEVICEEMCOOLS Brain.PadPassive external neck cooling with 1 EMCOOLS Brain.Pad

Timeline

Start date
2012-01-01
Primary completion
2012-05-01
Completion
2012-05-01
First posted
2012-04-24
Last updated
2012-08-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01584180. Inclusion in this directory is not an endorsement.